ESPR - Esperion Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts12121211
Avg. Estimate-1.94-2.06-2.77-3.62
Low Estimate-2.27-2.68-3.75-7.9
High Estimate-1.53-1.7-2.03-1.77
Year Ago EPS-1.86-2.24-7.54-2.77
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts11111111
Avg. Estimate810k810k148.03M175.63M
Low EstimateN/AN/A146.4M86.62M
High Estimate1.1M1.1M149M236.1M
Year Ago SalesN/AN/AN/A148.03M
Sales Growth (year/est)N/AN/AN/A18.60%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-1.63-1.420.74-1.86
EPS Actual-1.86-2.243.07-2.01
Difference-0.23-0.822.33-0.15
Surprise %-14.10%-57.70%314.90%-8.10%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.94-2.06-2.77-3.62
7 Days Ago-1.94-2.06-2.77-3.67
30 Days Ago-1.91-2.02-2.69-3.61
60 Days Ago-1.8-1.92-2.39-2.99
90 Days Ago-1.76-1.86-2.27-2.75
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/A1
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesESPRIndustrySectorS&P 500
Current Qtr.-4.30%N/AN/A-0.01
Next Qtr.8.00%N/AN/A0.07
Current Year63.30%N/AN/A-0.01
Next Year-30.70%N/AN/A0.14
Next 5 Years (per annum)28.30%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A